+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Interindividual differences in the response to statin therapy and gene polymorphisms related to myopathy during statin therapy

Interindividual differences in the response to statin therapy and gene polymorphisms related to myopathy during statin therapy

Giornale Italiano di Cardiologia 12(3): 182-185

The enzyme HMG-CoA reductase (HMGCR), the main site of action of statins, undergoes alternative splicing of exon 13, which encodes the binding domain of statins to the enzyme. The resulting isoform, called HMGCRv1, shows altered enzyme activity and sensitivity to statins compared to the classical isoform. This translates into interindividual differences in the response to treatment with these drugs. A recent discovery in the field of genetics has brought about the identification of the single nucleotide polymorphism rs4363657 of the SLCO1B1 gene located on chromosome 12. This polymorphism is strongly associated with myopathy induced by statins. From the available literature, a clinical study has evaluated the relationship between gene polymorphisms and myopathy during statin therapy. The study involved 12 000 patients treated with simvastatin at a dose of 80 mg/day. The odds ratio for myopathy was 4.5 (95% confidence interval 2.6-7.7) per copy of the C allele, and 16.9 (95% confidence interval 4.7-61.1) in CC as compared with TT homozygotes. Myopathy could be attributed to the C variant in more than 60% of cases. Genomic typing may allow the identification of these variants, leading to a tailored statin therapy with higher benefits to the patients and less adverse side effects.

(PDF emailed within 1 workday: $29.90)

Accession: 053914190

Download citation: RISBibTeXText

PMID: 21560474

Related references

A comparison of the efficacy of combined ezetimibe and statin therapy with doubling of statin dose in patients with remnant lipoproteinemia on previous statin therapy. Journal of Cardiology 60(1): 12-17, 2013

Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment. Journal of Pharmacy Practice 30(5): 521-527, 2016

A peri-operative statin update for non-cardiac surgery. Part I: The effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (non-surgical) patients. Anaesthesia 63(1): 52-64, 2007

Mislabeling of Study Design and Overstatement of Findings in "Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment". Journal of Pharmacy Practice 30(3): 385, 2018

Large copy-number variations in patients with statin-associated myopathy affecting statin myopathy-related loci. Physiological Research 65(6): 1005-1011, 2016

Interindividual differences of response to statin treatment cannot be explained by variations of the human gene for RhoA. Biochemical Genetics 43(3-4): 143-148, 2005

Statin therapy/lipid lowering therapy among Indian adults with first acute coronary event: The dyslipidemia Residual and Mixed Abnormalities IN spite of Statin therapy (REMAINS) study. Indian Heart Journal 68(5): 646-654, 2016

Statin therapy. Avoiding statin-related muscle side effects. Reviews in Cardiovascular Medicine 10(3): 180-181, 2009

Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clinical Cardiology 37(11): 653-659, 2015

Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting. European Journal of Clinical Pharmacology 72(3): 311-319, 2016

Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV--Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015. Journal of the American Heart Association 7(24): E010345-E010345, 2018

Tu-W27:4 Comparative lipid effects of combination therapy with a statin and extended-release niacin versus statin plus ezetimibe versus a statin alone. Atherosclerosis Supplements 7(3): 174-175, 2006

Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents. Journal of Physiology 590(24): 6389-6402, 2013

The effect of combined ezetimibe and statin therapy versus statin therapy alone on coronary plaque volume assessed by intravascular ultrasound: A systematic review and meta-analysis. Journal of Clinical Lipidology 12(5): 1133-1140.E15, 2018

Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease. Atherosclerosis 224(2): 454-456, 2013